| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.09 | 0.002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.002 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |